Search Results - "Headache"

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice by Ailani, Jessica, Burch, Rebecca C., Robbins, Matthew S.

“…Objective To incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive…”
Get full text

Headaches Associated With Personal Protective Equipment – A Cross‐Sectional Study Among Frontline Healthcare Workers During COVID‐19 by Ong, Jonathan J.Y., Bharatendu, Chandra, Goh, Yihui, Tang, Jonathan Z.Y., Sooi, Kenneth W.X., Tan, Yi Lin, Tan, Benjamin Y.Q., Teoh, Hock‐Luen, Ong, Shi T., Allen, David M., Sharma, Vijay K.

“…Background Coronavirus disease 2019 (COVID‐19) is an emerging infectious disease of pandemic proportions. Healthcare workers in Singapore working in high‐risk…”
Get full text

The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice

“…Objective To provide healthcare professionals with updated guidance in the use of novel preventive and acute treatments for migraine in adults. Background The…”
Get full text

The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic‐specific estimates from government health surveys by Burch, Rebecca, Rizzoli, Paul, Loder, Elizabeth

“…Background and Objectives Accurate, up‐to‐date estimates of the burden of migraine and severe headache are important for evidence‐based decision‐making about…”
Get full text

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study by Buse, Dawn C., Fanning, Kristina M., Reed, Michael L., Murray, Sharron, Dumas, Paula K., Adams, Aubrey Manack, Lipton, Richard B.

“…Objective To assess the effects of migraine on important life domains and compare differences between respondents with episodic and chronic migraine and…”
Get full text

The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies by Burch, Rebecca C., Loder, Stephen, Loder, Elizabeth, Smitherman, Todd A.

“…Background and Objectives The US National Center for Health Statistics, which is part of the Centers for Disease Control, conducts ongoing public health…”
Get full text

The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine by Edvinsson, Lars

“…The trigeminal ganglion plays a key role in primary headache pathophysiology. Calcitonin gene‐related peptide (CGRP) and CGRP receptors are expressed in…”
Get full text

The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review by Hindiyeh, Nada Ahmad, Zhang, Niushen, Farrar, Mallory, Banerjee, Pixy, Lombard, Louise, Aurora, Sheena K.

“…Background Migraine is a disabling primary headache disorder often associated with triggers. Diet‐related triggers are a common cause of migraine and certain…”
Get full text

Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States by Bonafede, Machaon, Sapra, Sandhya, Shah, Neel, Tepper, Stewart, Cappell, Katherine, Desai, Pooja

“…Objective The goal of this analysis was to provide a contemporary estimate of the burden of migraine, incorporating both direct and indirect costs, by…”
Get full text

Real‐World Patient Experience With Erenumab for the Preventive Treatment of Migraine by Robblee, Jennifer, Devick, Katrina L., Mendez, Natasha, Potter, Jamie, Slonaker, Jennifer, Starling, Amaal J.

“…Background Erenumab, a calcitonin gene‐related peptide (CGRP) receptor monoclonal antibody, has been well tolerated with good efficacy for the preventive…”
Get full text

Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial by Yarnitsky, David, Dodick, David W., Grosberg, Brian M., Burstein, Rami, Ironi, Alon, Harris, Dagan, Lin, Tamar, Silberstein, Stephen D.

“…Objective To assess the efficacy and safety of a remote electrical neuromodulation (REN) device for the acute treatment of migraine. Background There is a…”
Get full text

Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study by Barbanti, Piero, Aurilia, Cinzia, Cevoli, Sabina, Egeo, Gabriella, Fofi, Luisa, Messina, Roberta, Salerno, Antonio, Torelli, Paola, Albanese, Maria, Carnevale, Antonio, Bono, Francesco, D'Amico, Domenico, Filippi, Massimo, Altamura, Claudia, Vernieri, Fabrizio, Colombo, Bruno, Frediani, Fabio, Mercuri, Bruno, D'Onofrio, Florindo, Grazzi, Licia, Aguggia, Marco, Pierangeli, Giulia, Favoni, Valentina, Finocchi, Cinzia, Di Fiore, Paola, Costa, Carmelina Maria, Brunelli, Nicoletta, Fallacara, Adriana, Bertuzzo, Davide, Zucco, Maurizio, Di Clemente, Laura, Trimboli, Michele, Pascarella, Angelo, Manzo, Lucia

“…Objective To evaluate the long‐term effectiveness, safety, and tolerability of erenumab in a real‐world migraine population, looking for putative predictors of…”
Get full text

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study by Lipton, Richard B., Nicholson, Robert A., Reed, Michael L., Araujo, Andre B., Jaffe, Dena H., Faries, Douglas E., Buse, Dawn C., Shapiro, Robert E., Ashina, Sait, Cambron‐Mellott, M. Janelle, Rowland, John C., Pearlman, Eric M.

“…Objective The ObserVational survey of the Epidemiology, tReatment and Care of MigrainE (OVERCOME; United States) study is a multicohort, longitudinal web…”
Get full text

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences by Lipton, Richard B., Munjal, Sagar, Alam, Aftab, Buse, Dawn C., Fanning, Kristina M., Reed, Michael L., Schwedt, Todd J., Dodick, David W.

“…Objectives To summarize the baseline methods for the Migraine in America Symptoms and Treatment (MAST) Study and evaluate gender differences in…”
Get full text

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial by Croop, Robert, Madonia, Jennifer, Stock, David A., Thiry, Alexandra, Forshaw, Micaela, Murphy, Abigail, Coric, Vladimir, Lipton, Richard B.

“…Objective Evaluate the efficacy, safety, and tolerability of zavegepant nasal spray in the acute treatment of migraine. Background Calcitonin gene‐related…”
Get full text

Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines by Robbins, Matthew S., Starling, Amaal J., Pringsheim, Tamara M., Becker, Werner J., Schwedt, Todd J.

“…Background Cluster headache (CH), the most common trigeminal autonomic cephalalgia, is an extremely debilitating primary headache disorder that is often not…”
Get full text

Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis by Cameron, Chris, Kelly, Shannon, Hsieh, Shu-Ching, Murphy, Meghan, Chen, Li, Kotb, Ahmed, Peterson, Joan, Coyle, Doug, Skidmore, Becky, Gomes, Tara, Clifford, Tammy, Wells, George

“…Background Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative efficacy of triptans among each…”
Get full text

Hypertension: A new safety risk for patients treated with erenumab by Saely, Suprat, Croteau, David, Jawidzik, Laura, Brinker, Allen, Kortepeter, Cindy

“…Objective To identify and analyze postmarketing case reports of elevated blood pressure (BP) associated with erenumab use. Methods A retrospective analysis of…”
Get full text

Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention by Lipton, Richard B., Silberstein, Stephen D.

“…Migraine is a common disabling primary headache disorder that affects an estimated 36 million Americans. Migraine headaches often occur over many years or over…”
Get full text

Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial by Friedman, Deborah I., Quiros, Peter A., Subramanian, Prem S., Mejico, Luis J., Gao, Shan, McDermott, Michael, Wall, Michael

“…Objective To characterize the phenotype, headache‐related disability, medical co‐morbidities, use of symptomatic headache medications, and headache response to…”
Get full text